Oligohydramnios is characterized by the following features:
Diminished amniotic fluid volume (AFV)
Amniotic fluid volume of less than 500 mL at 32-36 weeks’ gestation – Amniotic fluid volume depends on the gestational age; therefore, the best definition may be AFI less than the fifth percentile.
Single deepest pocket (SDP) of less than 2 cm
Amniotic fluid index (AFI) of less than 5 cm or less than the fifth percentile
See the images below.
The earlier in pregnancy that oligohydramnios occurs, the poorer the prognosis. Fetal mortality rates as high as 80-90% have been reported with oligohydramnios diagnosed in the second trimester. Most of this mortality is a result of major congenital malformations and pulmonary hypoplasia secondary to PROM before 22 weeks’ gestation. Midtrimester PROM (premature rupture of membranes) often leads to pulmonary hypoplasia, fetal compression syndrome, and amniotic band syndrome. The inspiration of amniotic fluid at regular intervals is probably needed for terminal alveolar development.
The assessment of amniotic fluid volume is important in pregnancies complicated by abnormal fetal growth or IUGR. AFV has been shown to be predictive in discriminating normal from decreased growth. Oligohydramnios is a frequent finding in pregnancies involving IUGR and is most likely secondary to decreased fetal blood volume, renal blood flow, and, subsequently, fetal urine output. Pregnancies complicated by severe oligohydramnios have been shown to be at increased risk for fetal morbidity. [8, 9]
AFV is an important predictor of fetal well-being in pregnancies beyond 40 weeks’ gestation. AFV must be closely monitored, with measurements obtained at least once per week. The diagnosis of oligohydramnios may help in identifying postterm fetuses in jeopardy.
AFV is a predictor of the fetal tolerance of labor, and it is associated with an increased risk of abnormal heart rate, meconium-stained amniotic fluid, and cesarean delivery. An increased incidence of cord compression is associated with oligohydramnios; this can lead to variable decelerations, with cord occlusion as the proximate cause of fetal distress.
According to one study, pregnancies with decreased AFI between 24 and 34 weeks, including borderline AFI and oligohydramnios, were significantly more likely to be associated with major fetal malformations, and, in the absence of malformations, to be complicated by fetal growth restriction and preterm birth. Major malformations were more common in pregnancies with oligohydramnios (25%) and borderline AFI (10%) than in those with normal fluid (2%). 
Hydration (intravenous and oral) has been found to significantly improve the volume of amniotic fluid in third-trimester pregnancies with isolated oligohydramnios.  For more information, see Polyhydramnios and Oligohydramnios.
The diagnosis is confirmed by means of ultrasonography (see the images below). Oligohydramnios may be discovered incidentally during routine ultrasonography and noted during antepartum surveillance for other conditions. The diagnosis may be prompted by a lag in sequential fundal height measurements (size less than that expected for the dates) or by fetal parts that are easily palpated through the maternal abdomen. [12, 13, 14, 15, 16, 17]
During ultrasonography of the fetal anatomy, normal-appearing fetal kidneys and fluid-filled bladder may be observed to rule out renal agenesis (see the following 2 images), cystic dysplasia, and ureteral obstruction. Check fetal growth to rule out intrauterine growth restriction (IUGR) leading to oliguria.
Sterile speculum examination may be performed to check for range of motion (ROM). Amniotic fluid may pool in the vagina, and an arborization or ferning pattern may be observed when dried posterior vault fluid is examined microscopically. Cervical mucous may cause false-positive results, as can semen and blood. Nitrazine paper turns blue. The amniotic fluid is more basic (pH 6.5-7.0) than normal vaginal discharge (pH 4.5).
Initial studies to objectively measure amniotic fluid volume (AFV) involved dye dilution techniques. The techniques were accurate, although they required amniocentesis, an invasive procedure that increased the risk of perinatal morbidity.
The routine use of ultrasonography has created a safe, reliable, and repeatable method of measuring AFV. Early methods of assessing AFV with ultrasonography involved nonquantitative assessments, including sonographers’ subjective impression of AFV.
Subjective oligohydramnios criteria have included the following:
The absence of fluid pockets throughout the uterine cavity
Crowding of the fetal limbs
The absence of pockets surrounding the fetal legs
Overlapping of the fetal ribs (in severe cases)
The 2 most commonly used objective methods of determining AFV include measurement of the single deepest pocket (SDP) and the summation of the SDPs in each quadrant, or the amniotic fluid index (AFI).  These tests are routinely performed with the patient in the supine or semi-Fowler position, although studies have demonstrated accuracy in the lateral decubitus position as well. [9, 19, 20, 21, 22, 23]
The ultrasound transducer is held along the maternal longitudinal axis and maintained perpendicular to the floor while the SDP of the amniotic fluid is measured. Pockets should be free of fetal limbs and the umbilical cord, although some authors allow for a single loop of cord to be within the fluid pocket. AFV may be artificially increased if the transducer is not maintained perpendicular to the floor. excessive pressure on the maternal abdomen with the transducer may lead to an artificially reduced measurement (see the image below).
Phelan et al described the AFI as a quantitative measurement to predict a poor pregnancy outcome and the success of external cephalic versions.  The pregnant abdomen is divided into 4 quadrants by using the umbilicus as a reference point to divide the uterus into upper and lower halves and by using the linea nigra to divide the uterus into left and right halves. The 4 measurements are summed to obtain the AFI in centimeters. [20, 21]
In gestations earlier than 20 weeks, measurements from the 2 halves are divided by the linea nigra to obtain the AFI. Tables of the normal limits for AFI, based on the gestational age (see the Gestational Age from Estimated Date of Delivery calculator), have been published for singleton and multiple pregnancies (see an example below). The mean AFI for normal pregnancies is 11-16 cm.
The test is reproducible, with interobserver and intraobserver variations of about 10-15% or 1-2 cm in pregnancies with normal AFVs. The margin of error is less in patients with decreased amounts of amniotic fluid.
Oligohydramnios has been defined as an AFI less than 5 cm, although 8 cm has occasionally been used as a cut-off threshold. Because the AFV depends on the gestational age, oligohydramnios has been defined as an AFI less than the fifth percentile (corresponding to an AFI of < 6.8 cm at term).
Oligohydramnios has been defined as an SDP less than 2 cm. Perinatal morbidity rates have been shown to increase sharply with SDPs below this value. Some have suggested that an SDP of 2.5-3.0 cm is a better lower limit for separating normal SDPs from those consistent with oligohydramnios.
Many studies have shown that the SDP and the AFI methods have equal diagnostic accuracies. The SDP technique may be a better means of assessing the AFV in twin gestations and in pregnancies at an early gestational age. Some study results have shown that the AFI has greater sensitivity and a higher predictive value than the SDP in diagnosing abnormally high and low AFVs. Most obstetricians prefer to assess a broader area of the uterine cavity by using the AFI because the single measurement of the SDP does not allow for an asymmetric fetal position in the uterus.
According to a survey of members of the Society of Maternal-Fetal Medicine, deepest vertical pocket is considered to be the most accurate method of evaluating amniotic fluid in the second trimester, and amniotic fluid index is considered to be the most accurate method of evaluating fluid in the third trimester. Over 50% of respondents felt that oligohydramnios is overdiagnosed when using amniotic fluid index compared with deepest vertical pocket. 
Fetal mri can complement ultrasonography by providing better visualization in the fetus when ultrasound may be limited, in cases such as severe maternal obesity. Although mri may offer a larger field of view and better tissue contrast and not be limited by shadowing from osseous structures, it has a limited resolution when compared with ultrasonography and is less readily available and is more expensive. 
In 35 women with healthy singleton pregnancies, rapid MRI-based projection hydrography (PH) measurement was found to be a better predictor of amniotic fluid volume than ultrasonography (in utero at 28-32 weeks’ gestation). For the ultrasound measurements, single deepest vertical pocket (SDVP) measurement related most closely to amniotic fluid volume, with amniotic fluid index (AFI) demonstrating a weaker relationship. Manual multisection planimetry (MSP)-based measurement of AFV was used as a proxy reference standard. 
Finberg reported a possible pitfall in the sonographic analysis of amniotic fluid in twin pregnancies, the “amniotic wrinkle,” which may give the misleading impression of adequate amniotic fluid for both twins when one twin actually has little to none.
The author reevaluated sonograms of twin pregnancies in which an initial sonographer’s assessment was adequate fluid for each twin but which the author’s own imaging assessment on the same day showed oligohydramnios in one twin.
He found either of the following may occur when oligohydramnios of one twin is present:
The intertwin membrane may fold in on itself, creating an amniotic wrinkle (a short linear structure that extends perpendicularly away from the twin with decreased amniotic fluid in toward the amniotic space of the other twin)
An intrauterine sling or “cocoon” may be present, in which a fetus appears to be suspended within the amniotic space of the other twin may be present
Finberg recommended showing the intertwin membrane in all images used to document each twin’s amniotic fluid, with additional right-angle images to identify amniotic wrinkles. 
Phelan JP, Smith CV, Broussard P, Small M. Amniotic fluid volume assessment with the four-quadrant technique at 36-42 weeks’ gestation. J Reprod Med. 1987 Jul. 32(7):540-2. [Medline].
Dasari P, Niveditta G, Raghavan S. The maximal vertical pocket and amniotic fluid index in predicting fetal distress in prolonged pregnancy. Int J Gynaecol Obstet. 2007 Feb. 96(2):89-93. [Medline].
Fok WY, Chan LY, Lau TK. The influence of fetal position on amniotic fluid index and single deepest pocket. Ultrasound Obstet Gynecol. 2006 Aug. 28(2):162-5. [Medline].
Johnson JM, Chauhan SP, Ennen CS, Niederhauser A, Magann EF. A comparison of 3 criteria of oligohydramnios in identifying peripartum complications: a secondary analysis. Am J Obstet Gynecol. 2007 Aug. 197(2):207.e1-7; discussion 207.e7-8. [Medline].
Moore TR, Cayle JE. The amniotic fluid index in normal human pregnancy. Am J Obstet Gynecol. 1990 May. 162(5):1168-73. [Medline].
Peipert JF, Donnenfeld AE. Oligohydramnios: a review. Obstet Gynecol Surv. 1991 Jun. 46(6):325-39. [Medline].
Sherer DM. A review of amniotic fluid dynamics and the enigma of isolated oligohydramnios. Am J Perinatol. 2002 Jul. 19(5):253-66. [Medline].
Lee SE, Romero R, Lee SM, Yoon BH. Amniotic fluid volume in intra-amniotic inflammation with and without culture-proven amniotic fluid infection in preterm premature rupture of membranes. J Perinat Med. 2010. 38(1):39-44. [Medline].
Ross MG, Beall MH, Christenson PD. Amniotic fluid volume and perinatal outcome. Am J Obstet Gynecol. 2007 Mar. 196(3):e17. [Medline].
Petrozella LN, Dashe JS, McIntire DD, Leveno KJ. Clinical significance of borderline amniotic fluid index and oligohydramnios in preterm pregnancy. Obstet Gynecol. 2011 Feb. 117(2 Pt 1):338-42. [Medline].
Patrelli TS, Gizzo S, Cosmi E, Carpano MG, Di Gangi S, Pedrazzi G, et al. Maternal hydration therapy improves the quantity of amniotic fluid and the pregnancy outcome in third-trimester isolated oligohydramnios: a controlled randomized institutional trial. J Ultrasound Med. 2012 Feb. 31(2):239-44. [Medline].
Chamberlain PF, Manning FA, Morrison I, et al. Ultrasound evaluation of amniotic fluid volume. I. The relationship of marginal and decreased amniotic fluid volumes to perinatal outcome. Am J Obstet Gynecol. 1984 Oct 1. 150(3):245-9. [Medline].
Jaba B, Mohiuddin AS, Dey SN, Khan NA, Talukder SI. Ultrasonographic determination of amniotic fluid volume in normal pregnancy. Mymensingh Med J. 2005 Jul. 14(2):121-4. [Medline].
Magann EF, Chauhan SP, Barrilleaux PS, Whitworth NS, McCurley S, Martin JN. Ultrasound estimate of amniotic fluid volume: color Doppler overdiagnosis of oligohydramnios. Obstet Gynecol. 2001 Jul. 98(1):71-4. [Medline].
Moore TR. Sonographic screening for oligohydramnios: does it decrease or increase morbidity?. Obstet Gynecol. 2004 Jul. 104(1):3-4. [Medline].
Zlatnik MG, Olson G, Bukowski R, Saade GR. Amniotic fluid index measured with the aid of color flow Doppler. J Matern Fetal Neonatal Med. 2003 Apr. 13(4):242-5. [Medline].
Vink J, Hickey K, Ghidini A, Deering S, Mora A, Poggi S. Earlier gestational age at ultrasound evaluation predicts adverse neonatal outcomes in the preterm appropriate-for-gestational-age fetus with idiopathic oligohydramnios. Am J Perinatol. 2009 Jan. 26(1):21-5. [Medline].
Nabhan AF, Abdelmoula YA. Amniotic fluid index versus single deepest vertical pocket: a meta-analysis of randomized controlled trials. Int J Gynaecol Obstet. 2009 Mar. 104(3):184-8. [Medline].
Magann EF, Doherty DA, Chauhan SP, Busch FW, Mecacci F, Morrison JC. How well do the amniotic fluid index and single deepest pocket indices (below the 3rd and 5th and above the 95th and 97th percentiles) predict oligohydramnios and hydramnios?. Am J Obstet Gynecol. 2004 Jan. 190(1):164-9. [Medline].
Moore TR. Superiority of the four-quadrant sum over the single-deepest-pocket technique in ultrasonographic identification of abnormal amniotic fluid volumes. Am J Obstet Gynecol. 1990 Sep. 163(3):762-7. [Medline].
Rutherford SE, Phelan JP, Smith CV, Jacobs N. The four-quadrant assessment of amniotic fluid volume: an adjunct to antepartum fetal heart rate testing. Obstet Gynecol. 1987 Sep. 70(3 Pt 1):353-6. [Medline].
Magann EF, Sandlin AT, Ounpraseuth ST. Amniotic fluid and the clinical relevance of the sonographically estimated amniotic fluid volume: oligohydramnios. J Ultrasound Med. 2011 Nov. 30(11):1573-85. [Medline].
Morris RK, Meller CH, Tamblyn J, Malin GM, Riley RD, Kilby MD, et al. Association and prediction of amniotic fluid measurements for adverse pregnancy outcome: systematic review and meta-analysis. BJOG. 2014 May. 121(6):686-99. [Medline].
Quinones JN, Reynolds RM, Rochon ML, Brown KK, Smulian JC. A survey of perinatologists: amniotic fluid index or deepest vertical pocket?. Obstet Gynecol. 2014 May. 123 Suppl 1:194S-6S. [Medline].
Pistorius LR, Hellmann PM, Visser GH, Malinger G, Prayer D. Fetal neuroimaging: ultrasound, MRI, or both?. Obstet Gynecol Surv. 2008 Nov. 63(11):733-45. [Medline].
Hilliard NJ, Hawkes R, Patterson AJ, Graves MJ, Priest AN, Hunter S, et al. Amniotic fluid volume: Rapid MR-based assessment at 28-32 weeks gestation. Eur Radiol. 2016 Jan 20. [Medline].
Rubesova E, Barth RA. Advances in fetal imaging. Am J Perinatol. 2014 Aug. 31 (7):567-76. [Medline].
Finberg HJ. The amniotic wrinkle: a pitfall in evaluating amniotic fluid for twins. J Ultrasound Med. 2010 Feb. 29(2):249-54. [Medline].
Jason K Baxter, MD, MS Fellow in Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Thomas Jefferson University Hospital
Jason K Baxter, MD, MS is a member of the following medical societies: American College of Obstetricians and Gynecologists, Association of Professors of Gynecology and Obstetrics, Society for Maternal-Fetal Medicine, American Medical Association, Sigma Xi
Disclosure: Nothing to disclose.
Harish M Sehdev, MD Professor of Clinical Obstetrics and Gynecology, Department of Obstetrics and Gynecology, University of Pennsylvania School of Medicine; Consulting Staff, Pennsylvania Hospital, University of Pennsylvania Health System
Harish M Sehdev, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Obstetricians and Gynecologists, American Institute of Ultrasound in Medicine, Phi Beta Kappa, Society for Maternal-Fetal Medicine
Disclosure: Nothing to disclose.
John W Breckenridge, MD Clinical Assistant Professor, Department of Radiology, Division of Ultrasound, Thomas Jefferson University Hospital; Chair, Department of Radiology, Abington Memorial Hospital
John W Breckenridge, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Radiology, American Institute of Ultrasound in Medicine, American Medical Association, Pennsylvania Medical Society
Disclosure: Nothing to disclose.
Bernard D Coombs, MB, ChB, PhD Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand
Disclosure: Nothing to disclose.
Karen L Reuter, MD, FACR Professor, Department of Radiology, Lahey Clinic Medical Center
Karen L Reuter, MD, FACR is a member of the following medical societies: American Association for Women Radiologists, American College of Radiology, American Institute of Ultrasound in Medicine, American Roentgen Ray Society, Radiological Society of North America
Disclosure: Nothing to disclose.
Eugene C Lin, MD Attending Radiologist, Teaching Coordinator for Cardiac Imaging, Radiology Residency Program, Virginia Mason Medical Center; Clinical Assistant Professor of Radiology, University of Washington School of Medicine
Eugene C Lin, MD is a member of the following medical societies: American College of Nuclear Medicine, American College of Radiology, Radiological Society of North America, Society of Nuclear Medicine and Molecular Imaging
Disclosure: Nothing to disclose.
Research & References of Oligohydramnios Imaging|A&C Accounting And Tax Services